Fungal Infection
94
5
6
62
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
21 trials with published results (22%)
Research Maturity
62 completed trials (66% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.4%
6 terminated out of 94 trials
91.2%
+4.7% vs benchmark
28%
26 trials in Phase 3/4
34%
21 of 62 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 62 completed trials
Clinical Trials (94)
Fungal Biomarkers to Reduce Duration of Empirical Antifungal Therapy: a Randomized Comparative Study (STAFE)
Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal Infection
CD5CAR-NK Cells for Refractory Invasive Mold Disease
Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors
COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI)
Fungal Vascular Graft Infections, French Multicenter Retrospective Study
PTX3-targeted Antifungal Prophylaxis
Rezafungin Prophylaxis in Liver Transplant
Study to Assess Safety, Tolerability and Pharmacokinetics of APX001 Administered by Intravenous Infusion to Healthy Subjects
Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally
Isavuconazole in Critically Ill Patients: Efficacy and Safety
Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants
Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS
Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients
Relationship Between Fungal Colonization and Severe Bronchopulmonary Dysplasia
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant
The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis
Multicenter Cohort Study of Invasive Fungal Filamentous Fungal Infections in Liver Transplant Patients